E. Wenzel

2.3k total citations
110 papers, 1.5k citations indexed

About

E. Wenzel is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, E. Wenzel has authored 110 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Hematology, 29 papers in Pulmonary and Respiratory Medicine and 21 papers in Surgery. Recurrent topics in E. Wenzel's work include Platelet Disorders and Treatments (29 papers), Blood properties and coagulation (26 papers) and Venous Thromboembolism Diagnosis and Management (18 papers). E. Wenzel is often cited by papers focused on Platelet Disorders and Treatments (29 papers), Blood properties and coagulation (26 papers) and Venous Thromboembolism Diagnosis and Management (18 papers). E. Wenzel collaborates with scholars based in Germany, United States and Austria. E. Wenzel's co-authors include F. Jung, H. Kiesewetter, C. Mrowietz, G. Pindur, Peter Hellstern, К. Schimrigk, J. Treib, Jürgen Koscielny, Markus T. Grauer and A. Haaß and has published in prestigious journals such as Journal of Hepatology, Anesthesia & Analgesia and Drugs.

In The Last Decade

E. Wenzel

99 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Wenzel Germany 22 427 351 303 266 264 110 1.5k
Thomas Slaughter United States 20 320 0.7× 508 1.4× 260 0.9× 403 1.5× 287 1.1× 49 1.3k
Iren B. Kovács United Kingdom 22 302 0.7× 326 0.9× 72 0.2× 189 0.7× 446 1.7× 80 1.3k
Scott H. Goodnight United States 24 493 1.2× 698 2.0× 116 0.4× 277 1.0× 472 1.8× 60 2.5k
A. van de Wiel Netherlands 25 423 1.0× 236 0.7× 115 0.4× 66 0.2× 219 0.8× 73 1.8k
Rob J. Kraaijenhagen Netherlands 25 806 1.9× 151 0.4× 106 0.3× 77 0.3× 101 0.4× 46 1.6k
Michael Desborough United Kingdom 20 420 1.0× 264 0.8× 279 0.9× 126 0.5× 171 0.6× 68 1.4k
Juana Vallés Spain 19 401 0.9× 275 0.8× 85 0.3× 228 0.9× 608 2.3× 65 1.7k
M. Livio Italy 23 572 1.3× 308 0.9× 65 0.2× 334 1.3× 553 2.1× 54 1.8k
Neil Boyce Australia 29 105 0.2× 430 1.2× 216 0.7× 418 1.6× 130 0.5× 81 2.3k
Philip C. Comp United States 20 691 1.6× 664 1.9× 136 0.4× 264 1.0× 1.4k 5.5× 48 2.9k

Countries citing papers authored by E. Wenzel

Since Specialization
Citations

This map shows the geographic impact of E. Wenzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Wenzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Wenzel more than expected).

Fields of papers citing papers by E. Wenzel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Wenzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Wenzel. The network helps show where E. Wenzel may publish in the future.

Co-authorship network of co-authors of E. Wenzel

This figure shows the co-authorship network connecting the top 25 collaborators of E. Wenzel. A scholar is included among the top collaborators of E. Wenzel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Wenzel. E. Wenzel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krischek, Boris, Werner Brannath, Ute Klinkhardt, et al.. (2005). Role of the Retention Test Homburg in Evaluating Platelet Hyperactivity and in Monitoring Therapy with Antiplatelet Drugs. Seminars in Thrombosis and Hemostasis. 31(4). 458–463.
2.
Halbmayer, Walter‐Michael, Götz Nowak, & E. Wenzel. (2005). Reliability of Platelet Function Tests and Drug Monitoring. Seminars in Thrombosis and Hemostasis. 31(4). 367–369.
3.
Nickels, Ruth M., U.T. Seyfert, E. Wenzel, Michael D. Menger, & Brigitte Vollmar. (2003). A simple and reproducible method to reliably assess platelet activation. Thrombosis Research. 110(1). 53–56. 1 indexed citations
4.
Schenk, Joachim, et al.. (1999). Analysis and Occurrence of Adverse Events with Oral Anticoagulant Therapy. Seminars in Thrombosis and Hemostasis. 25(1). 65–71. 11 indexed citations
5.
Schenk, Joachim, et al.. (1999). The “Phoenix” ADR Database of the Drug Commission of the German Medical Profession-A Clinically Useful Approach to Optimize Evidence-Based Medicine in Germany. Seminars in Thrombosis and Hemostasis. 25(1). 57–64. 21 indexed citations
6.
Treib, J., G. Pindur, Markus T. Grauer, et al.. (1996). Influence of Low Molecular Weight Hydroxyethyl Starch (HES 40/0.5-0.55) on Hemostasis and Hemorheology. Pathophysiology of Haemostasis and Thrombosis. 26(5). 258–265. 18 indexed citations
7.
Koscielny, Jürgen, F. Jung, C. Mrowietz, et al.. (1995). Rheologische und kapillarmikroskopische Größen zur Diagnostik des von-Willebrand-Jürgens-Syndroms. Transfusion Medicine and Hemotherapy. 22(Suppl. 1). 45–47. 1 indexed citations
8.
Jung, F., et al.. (1995). Qualität von Erythrozytenkonzentraten aus rheologischer Sicht. Transfusion Medicine and Hemotherapy. 22(Suppl. 1). 51–53. 1 indexed citations
9.
Jung, F., Jürgen Koscielny, C. Mrowietz, et al.. (1994). Elimination kinetics of different hydroxyethyl starches and effects on blood fluidity. Clinical Hemorheology and Microcirculation. 14(2). 189–202. 9 indexed citations
10.
Hellstern, Peter, et al.. (1990). Monitoring of intravenous heparin therapy by a modified chromogenic anti factor xa assay. Annals of Hematology. 60(2). 114. 2 indexed citations
11.
Jung, F., Jürgen Koscielny, C. Mrowietz, et al.. (1990). Einfluß der Hämodilution auf den systemischen und den Kapillarhämatokrit. Transfusion Medicine and Hemotherapy. 17(5). 268–275. 6 indexed citations
12.
Seifried, Erhard, et al.. (1988). In vivo recovery and half-life time of a steam-treated factor IX concentrate in hemophilia B patients. Annals of Hematology. 57(6). 341–345. 6 indexed citations
13.
14.
Hellstern, Peter, HOLGER SCHWERDT, Cem Özbek, et al.. (1987). High-Dose Systemic Streptokinase and Acylated Streptokinase-Plasminogen Complex (BRL 26921) in Acute Myocardial Infarction: Alterations of the Fibrinolytic System and Clearance of Fibrinolytic Activity. Pathophysiology of Haemostasis and Thrombosis. 17(1-2). 32–39. 17 indexed citations
15.
Hellstern, Peter, et al.. (1987). Measurement of Factor VIII Procoagulant Antigen in Normal Subjects and in Hemophilia A Patients by an Immunoradiometric Assay and by an Enzyme-Linked Immunosorbent Assay. Pathophysiology of Haemostasis and Thrombosis. 17(4). 173–181. 4 indexed citations
16.
Jung, F., et al.. (1986). Comparative investigation of the microcirculation in patients with hypertension and healthy adults.. PubMed. 64(19). 956–61. 17 indexed citations
17.
Hellstern, Peter, et al.. (1985). Gray platelet syndrome: Selective ?-granule deficiency and thrombocytopenia due to increased platelet turnover. Annals of Hematology. 50(6). 331–340. 31 indexed citations
18.
Hellstern, Peter, et al.. (1985). The use of heat-treated factor VIII-concentrates in von willebrand's disease. Annals of Hematology. 50(1). 25–27. 19 indexed citations
19.
Hellstern, Peter, et al.. (1985). Combined Dys-Form of Homozygous Factor XI Deficiency and Heterozygous Factor XII Deficiency. Pathophysiology of Haemostasis and Thrombosis. 15(3). 215–219. 4 indexed citations
20.
Miyashita, C., et al.. (1984). In vitro characterization of commercial factor VIII concentrates: Long-term follow-up. Annals of Hematology. 49(1). 53–59. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026